Answers are grounded in this paper and cite their sources.
Our data suggest for the first time that PD-L1 status may be a new predictor of prognosis for patients with pancreatic cancer and provide the rationale for developing a novel therapy of targeting the PD-L/PD-1 pathway against this fatal disease.
No takes yet. Share an insight, caveat, or question.
Nomi et al. (2007) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: